Frailty in HIV-infected adults in South Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 1, 2013, Pages 43-51

  Pathai, Sophia ^a,d   Gilbert, Clare ^a   Weiss, Helen A ^a   Cook, Colin ^b,c   Wood, Robin ^d   Bekker, Linda Gail ^d   Lawn, Stephen D ^a,d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

AIDS; frailty; HIV; premature ageing; South Africa

Indexed keywords

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; CLINICAL ASSESSMENT; CONTROLLED STUDY; EXHAUSTION; FEMALE; FRAILTY; GRIP STRENGTH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; MAJOR CLINICAL STUDY; MALE; MEDICAL PARAMETERS; PHYSICAL ACTIVITY; PREDICTION; PRIORITY JOURNAL; SMOKING; SOUTH AFRICA; TREATMENT DURATION; VIRUS LOAD; WALKING; WEIGHT REDUCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; SEX FACTORS; SOUTH AFRICA;

EID: 84872075650     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318273b631     Document Type: Article

References (38)

1. Mocroft A, Brettle R, Kirk O, et al. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16:1663-1671.
2. The Antiretroviral Therapy Cohort Collaboration. Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996-2006: collaborative analysis of 13 HIV cohort studies. Clin Infect Dis. 2010;50: 1387-1396.
3. El-Sadr WM, Lundgren JD, Neaton JD, et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283-2296.
4. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med. 2009;17:118-123.
5. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med. 2007; 146:87-95.
6. Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120-1126.
7. Fulop T, Larbi A, Witkowski JM, et al. Aging, frailty and age-related diseases. Biogerontology. 2010;11:547-563.
8. Hubbard RE, Woodhouse KW. Frailty, inflammation and the elderly. Biogerontology. 2010;11:635-641.
9. Desquilbet L, Margolick JB, Fried LP, et al. Relationship between a frailtyrelated phenotype and progressive deterioration of the immune system in HIV-infected men. J Acquir Immune Defic Syndr. 2009;50:299-306.
10. Onen NF, Agbebi A, Shacham E, et al. Frailty among HIV-infected persons in an urban outpatient care setting. J Infect. 2009;59:346-352.
11. Terzian AS, Holman S, Nathwani N, et al. Factors associated with preclinical disability and frailty among HIV-infected and HIV-uninfected women in the era of cART. J Womens Health (Larchmt). 2009;18:1965-1974.
12. Desquilbet L, Jacobson LP, Fried LP, et al. HIV-1 infection is associated with an earlier occurrence of a phenotype related to frailty. J Gerontol A Biol Sci Med Sci. 2007;62:1279-1286.
13. Mills EJ, Rammohan A, Awofeso N. Ageing faster with AIDS in Africa. Lancet. 2011;377:1131-1133.
14. Mills EJ, Bärnighausen T, Negin J. HIV and aging-preparing for the challenges ahead. N Engl J Med. 2012;366:1270-1273.
15. Lawn SD, Myer L, Bekker LG, et al. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006;20:1605-1612.
16. Lawn SD, Myer L, Orrell C, et al. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS. 2005;19:2141-2148.
17. Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56: M146-M156.
18. Cesari M, Kritchevsky SB, Penninx BW, et al. Prognostic value of usual gait speed in well-functioning older people-results from the Health, Aging and Body Composition Study. J Am Geriatr Soc. 2005;53: 1675-1680.
19. Margolick JB, Li X, Detels R, et al. Earlier occurrence of the frailty phenotype in HIV+ men than in HIV-men. Paper presented at: 18th Conference on Retroviruses and Opportunistic Infections. Boston, MA; February 27-March 2, 2011.
20. Onen NF, Patel P, Baker J, et al. Frailty and pre-frailty in a contemporary cohort of HIV+ adults. 19th Conference on Retroviruses and Opportunistic Infections. Seattle, WA; March 5-8, 2012.
21. Lawn SD, Little F, Bekker LG, et al. Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South Africa. AIDS. 2009;23:335-342.
22. Lawn SD, Myer L, Edwards D, et al. Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS. 2009;23:1717-1725.
23. Battegay M, Nuesch R, Hirschel B, et al. Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis. 2006;6:280-287.
24. Babiker AG, Emery S, Fätkenheuer G, et al. Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. Clin Trials. E-pub ahead of print: 2012.
25. Puts MT, Lips P, Deeg DJ. Sex differences in the risk of frailty for mortality independent of disability and chronic diseases. J Am Geriatr Soc. 2005;53:40-47.
26. Avila-Funes JA, Helmer C, Amieva H, et al. Frailty among communitydwelling elderly people in France: the three-city study. J Gerontol A Biol Sci Med Sci. 2008;63:1089-1096.
27. Walston J, Fried LP. Frailty and the older man. Med Clin North Am. 1999;83:1173-1194.
28. Joseph C, Kenny AM, Taxel P, et al. Role of endocrine-immune dysregulation in osteoporosis, sarcopenia, frailty and fracture risk. Mol Aspects Med. 2005;26:181-201.
29. Gasparotto AS, Sprinz E, Lazzaretti RK, et al. Genetic polymorphisms in estrogen receptors and sexual dimorphism in fat redistribution in HIV-infected patients on HAART. AIDS. 2012;26:19-26.
30. Negin J, Cumming RG. HIV infection in older adults in sub-Saharan Africa: extrapolating prevalence from existing data. Bull World Health Organ. 2010;88:847-853.
31. World Health Organisation. GLOBAL HIV/AIDS RESPONSE: Epidemic Update and Health Sector Progress Towards Universal Access, Progress Report 2011. Geneva, Switzerland: WHO, UNICEF, UNAIDS; 2011:97.
32. Capeau J. Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses. Clin Infect Dis. 2011;53: 1127-1129.
33. Souza PMLD, Jacob-Filho W, Santarém JM, et al. Effect of progressive resistance exercise on strength evolution of elderly patients living with HIV compared to healthy controls. Clinics (Sao Paulo). 2011;66:261-266.
34. Fisher M, Cooper V. HIV and ageing: premature ageing or premature conclusions? Curr Opin Infect Dis. 2012;25:1-3.
35. Martin J, Volberding P. HIV and premature aging: a field still in its infancy. Ann Intern Med. 2010;153:477-479.
36. Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;45:1593-1601.
37. Johnson L, Budlender D. HIV Risk Factors: A Review of the Demographic, Socio-Economic, Biomedical and Behavioural Determinants of HIV Prevalence in South Africa; Centre for Acurial Research, University of Cape Town; 2002. Cape Town, South Africa: CARE Monograph No 8.
38. Desquilbet L, Jacobson LP, Fried LP, et al. A frailty-related phenotype before HAART initiation as an independent risk factor for AIDS or death after HAART among HIV-infected men. J Gerontol A Biol Sci Med Sci. 2011;66:1030-1038.